| 000 | 01537 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513084823.0 | ||
| 264 | 0 | _c19960312 | |
| 008 | 199603s 0 0 eng d | ||
| 022 | _a0920-3206 | ||
| 024 | 7 |
_a10.1007/BF00878550 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDobs, A S | |
| 245 | 0 | 0 |
_aChanges in serum lipoprotein(a) in hyperlipidemic subjects undergoing long-term treatment with lipid-lowering drugs. _h[electronic resource] |
| 260 |
_bCardiovascular drugs and therapy _cOct 1995 |
||
| 300 |
_a677-84 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCholestyramine Resin _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperlipidemias _xblood |
| 650 | 0 | 4 |
_aLipoprotein(a) _xblood |
| 650 | 0 | 4 |
_aLovastatin _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPravastatin _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aPrasad, M | |
| 700 | 1 | _aGoldberg, A | |
| 700 | 1 | _aGuccione, M | |
| 700 | 1 | _aHoover, D R | |
| 773 | 0 |
_tCardiovascular drugs and therapy _gvol. 9 _gno. 5 _gp. 677-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00878550 _zAvailable from publisher's website |
| 999 |
_c8572610 _d8572610 |
||